Stephen T. Chen, PhD, Chairman of the Board and Chief Executive Officer, has been a director since February 1996. Dr. Chen has over thirty years of experience in the pharmaceutical industry, including an extensive background in pharmaceutical product acquisition and licensing, development of joint venture agreements, execution of business strategy, and leadership of start-up companies in the pharmaceutical, biotechnology and nutraceutical industries. Dr. Chen has held executive positions in R&D and business development at several major pharmaceutical companies, including Burroughs Wellcome (presently GlaxoSmithKline), Miles Pharmaceuticals (presently Bayer), ICI America (presently AstraZeneca), and Ciba-Geigy (presently Novartis). He received a PhD degree in Industrial and Physical Pharmacy from Purdue University in 1977 with an emphasis on drug delivery systems.

Bernard H. Cohen, Chief Financial Officer and Vice President for Finance, joined AMAR in October 2009. Mr. Cohen brings over 30 years of management experience to the company. Previously, Mr. Cohen was Director of Finance and Data Base Manager at Harrington Regional Medical Center in Amarillo. Prior, he held various executive positions at Colbert’s department store of Amarillo holding the position of CEO, Vice President, Controller, and Personnel Director. Mr. Cohen holds a Masters of Professional Accounting degree (MPA) and a B.B.A. of Business Administration from West Texas A&M University.

Edward L. Morris, JD, Corporate Secretary and Counsel, has provided legal services to AMAR since 1984. He graduated from Harvard Law School after earning an undergraduate degree from Yale University. Mr. Morris began his practice in securities law with the Houston firm of Vinson, Elkins in the 1970’s, then returned to Amarillo in 1978, where he engaged in the private practice of law through February 2011.

Copyright © 2018 Amarillo Biosciences. All Rights Reserved.
Built and hosted by Dark Roast Hosting